Grundläggande statistik
| LEI | 54930052SRG011710797 |
| CIK | 1035267 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Intuitive Surgical, Inc.
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| May 28, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2026 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| May 28, 2026 |
Exhibit 99.1 Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton Current Chief Commercial and Marketing Officer Henry Charlton to become SVP of Global Business Operations SUNNYVALE, Calif., May 28, 2026 (GLOBE NEWSWIRE) - Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotio |
|
| May 21, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 1020 Kifer Road Sunnyvale, California 94086 (Address of principal execu |
|
| May 21, 2026 |
Exhibit 1.01 CONFLICT MINERALS REPORT Pursuant to Rule 13P-1 under the Securities Exchange Act (17 CFR 240.13P-1) FOR THE REPORTING PERIOD FROM JANUARY 1, 2025 TO DECEMBER 31, 2025 I. INTRODUCTION This Conflict Minerals Report (“report”) of Intuitive Surgical, Inc. (“Intuitive,” “we,” or “us”) for the year ended December 31, 2025, is presented to comply with Rule 13p-1 under the Securities Exchang |
|
| May 4, 2026 |
EXHIBIT 10.1 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN (Amendment and Restatement Adopted by the Board of Directors on January 29, 2026) (Approved by the Shareholders on April 30, 2026) Article 1. PURPOSE The purpose of the Intuitive Surgical, Inc. 2010 Incentive Award Plan, as amended and restated from time to time (the “Plan”) is to promote the success and enhance t |
|
| May 4, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2026 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| April 22, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive |
|
| April 21, 2026 |
INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS SUNNYVALE, CALIF. April 21, 2026 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2026. Q1 Highlights •Worldwide procedures (da Vinci and Ion |
|
| April 21, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2026 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commission |
|
| March 13, 2026 |
2025 Annual Report2025 Intuitive Annual Report 1. Procedures performed in 2005 by geography. 2. Procedures performed in 2015 by geography. 3. Procedures performed in 2025 by geography. 4. Cumulative procedures performed using Intuitive systems includes da Vinci and Ion through 2025. Dear Owner, I started with Intuitive in March of 1996 as a mechanical engineer responsible for designing several asp |
|
| March 13, 2026 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confid |
|
| March 13, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of |
|
| March 2, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2026 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commission |
|
| March 2, 2026 |
Exhibit 99.1 Intuitive Expands Investment and Footprint in Europe Company begins direct operations in Italy, Spain, Portugal, Malta, San Marino, and associated territories SUNNYVALE, Calif., March 2, 2026 (GLOBE NEWSWIRE) - Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the completion of its acquisition of |
|
| February 3, 2026 |
Exhibit 21.1 INTUITIVE SURGICAL, INC. SUBSIDIARIES (All 100% owned other than Guanxing Medical Device (Beijing) Co., Ltd., Intuitive Surgical-Fosun (HongKong) Co., Ltd., Intuitive Surgical-Fosun Medical Device (Hainan) Co., Ltd., Intuitive Surgical-Fosun Medical Device (Tianjin) Co., Ltd., and Intuitive Surgical-Fosun Medical Technology (Shanghai) Co., Ltd.) Subsidiaries of the Registrant State or |
|
| February 3, 2026 |
Exhibit 19 INTUITIVE SURGICAL, INC. INSIDER TRADING POLICY AND GUIDELINES As Amended and Restated on January 29, 2026. Purpose This Insider Trading Policy and Guidelines (the “Policy”) summarizes the insider trading rules and explains how Insiders may engage in Securities Transactions, so they are in compliance with the laws prohibiting insider trading. This Policy also described the consequences |
|
| February 3, 2026 |
INTUITIVE SURGICAL, INC. CLAWBACK POLICY (as amended January 29, 2026) Exhibit 97.1 INTUITIVE SURGICAL, INC. CLAWBACK POLICY (as amended January 29, 2026) Intuitive Surgical, Inc. (the “Company”) has adopted this Clawback Policy (the “Policy”), originally effective as of October 2, 2023 (the “Effective Date”). Capitalized terms used in the text of this Policy but not otherwise defined herein are defined in Section 11. 1.Persons Subject to Policy This Policy shall app |
|
| February 3, 2026 |
Exhibit 10.10 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN GLOBAL RESTRICTED STOCK UNIT GRANT NOTICE Intuitive Surgical, Inc., a Delaware corporation (the “Company”), pursuant to its Amended and Restated 2010 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant”) the number of Restricted Stock Units (the |
|
| February 3, 2026 |
Exhibit 10.11 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN PERFORMANCE STOCK UNIT AWARD GRANT NOTICE Intuitive Surgical, Inc., a Delaware corporation (the “Company”), pursuant to its Amended and Restated 2010 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (the “Participant”), an award of performance stock units ( |
|
| February 3, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-307 |
|
| January 22, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2026 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| January 22, 2026 |
INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS SUNNYVALE, CALIF. January 22, 2026 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2025. Q4 Highlights •Worldwide procedures (da Vinci a |
|
| January 14, 2026 |
INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 RESULTS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 RESULTS SUNNYVALE, CALIF. January 14, 2026 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial re |
|
| January 14, 2026 |
Exhibit 99.2 Intuitive Surgical, Inc. Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics Three Months Ended Twelve Months Ended December 31, 2025 December 31, 2024 Change December 31, 2025 December 31, 2024 Change Revenue ($millions) Instruments and accessories (“I&A”) $ 1,658.3 $ 1,411.5 17 % % $ 6,018.9 $ 5,079.0 19 % % Systems 785.9 654.6 20 % % 2,473.7 1,966.0 26 % % Service 4 |
|
| January 14, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 14, 2026 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| December 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2025 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| October 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuit |
|
| October 21, 2025 |
INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS SUNNYVALE, CALIF. October 21, 2025 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2025. Q3 Highlights •Worldwide procedures (da Vinci a |
|
| October 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2025 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| September 4, 2025 |
144 0001781750 XXXXXXXX LIVE 0001035267 INTUITIVE SURGICAL, INC. 000-30713 1020 KIFER ROAD SUNNYVALE CA 94086 (408) 523-2100 AMY L LADD Director Common Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004 335 147631.15 358476506 09/04/2025 NASDAQ Common 04/25/2024 Restricted Stock ISSUER N 335 04/25/2024 Not Applicable N AMY L LADD 1020 KIFER RO |
|
| September 3, 2025 |
144 0001781750 XXXXXXXX LIVE 0001035267 INTUITIVE SURGICAL, INC. 000-30713 1020 KIFER ROAD SUNNYVALE CA 94086 (408) 523-2100 AMY L LADD Director Common Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004 336 157956.96 358476506 09/03/2025 NASDAQ Common 04/27/2023 Restricted Stock ISSUER N 102 04/27/2023 Not Applicable Common 04/25/2024 Restrict |
|
| August 29, 2025 |
144 0001280628 XXXXXXXX LIVE 0001035267 INTUITIVE SURGICAL, INC. 000-30713 1020 KIFER ROAD SUNNYVALE CA 94086 (408) 523-2100 GARY S GUTHART Officer Director Common Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004 29360 13872227.13 358476506 08/29/2025 NASDAQ Common 08/29/2025 Stock Option Exercise ISSUER N 29360 08/29/2025 Cash N GARY S GUTH |
|
| July 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTUITIVE SURGICAL, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 77-0416458 (I.R.S. Employer Identification No.) 1020 Kifer Road Sunnyvale, California 94086 (Address of Principal Executive Offices including Zip Cod |
|
| July 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive S |
|
| July 23, 2025 |
Exhibit 107.1 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) Intuitive Surgical, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title (1) Fee Calculation Rule Amount Registered (2) Proposed Maximum Offering Price Per Unit (3) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stock |
|
| July 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2025 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commission |
|
| July 22, 2025 |
INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS SUNNYVALE, CALIF. July 22, 2025 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2025. Q2 Highlights •Worldwide da Vinci procedures grew appr |
|
| May 23, 2025 |
Conflict Minerals Report for the reporting period January 1, Exhibit 1.01 CONFLICT MINERALS REPORT Pursuant to Rule 13P-1 under the Securities Exchange Act (17 CFR 240.13P-1) FOR THE REPORTING PERIOD FROM JANUARY 1, 2024, TO DECEMBER 31, 2024 I. INTRODUCTION This Conflict Minerals Report (“report”) of Intuitive Surgical, Inc. (“Intuitive,” “we,” or “us”) for the year ended December 31, 2024, is presented to comply with Rule 13p-1 under the Securities Exchan |
|
| May 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 1020 Kifer Road Sunnyvale, California 94086 (Address of principal execu |
|
| May 15, 2025 |
Exhibit 99.1 Contact: Global Public Affairs +1-202-997-7373 Intuitive Announces CEO Transition Effective July 1, 2025 President Dave Rosa promoted to CEO Current CEO Gary Guthart to become executive chair of Intuitive’s board Current Board Chair Craig Barratt to become lead independent director Sunnyvale, Calif., May 15, 2025 – Intuitive (NASDAQ: ISRG), a global technology leader in minimally inva |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2025 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission F |
|
| May 5, 2025 |
Intuitive Surgical, Inc. Amended and Restated 2010 Incentive Award Plan, as amended and restated. EXHIBIT 10.1 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN (Amendment and Restatement Adopted by the Board of Directors on January 30, 2025) (Approved by the Shareholders on May 1, 2025) ARTICLE 1. PURPOSE The purpose of the Intuitive Surgical, Inc. 2010 Incentive Award Plan, as amended and restated from time to time (the “Plan”) is to promote the success and enhance the |
|
| May 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2025 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive |
|
| April 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2025 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commission |
|
| April 22, 2025 |
INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS SUNNYVALE, CALIF. April 22, 2025 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2025. Q1 Highlights •Worldwide da Vinci procedures grew app |
|
| March 14, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confid |
|
| March 14, 2025 |
Annual Report 2024Intuitive Annual Report 2024 Dear Owner, I’d like to start this year’s note to you by stepping back and examining what motivates our teams at Intuitive. |
|
| March 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of |
|
| January 31, 2025 |
Intuitive Surgical, Inc. Subsidiaries. Exhibit 21.1 INTUITIVE SURGICAL, INC. SUBSIDIARIES (All 100% owned other than Intuitive Surgical-Fosun (HongKong) Co., Ltd., Intuitive Surgical-Fosun Medical Device (Tianjin) Co., Ltd., and Intuitive Surgical-Fosun Medical Technology (Shanghai) Co., Ltd.) Subsidiaries of the Registrant State or Other Jurisdiction of Incorporation Intuitive Fluorescence Imaging LLC Delaware, U.S. Intuitive Surgical |
|
| January 31, 2025 |
INTUITIVE SURGICAL, INC. INSIDER TRADING POLICY AND GUIDELINES As Amended and Restated on April 27, 2023. 1.STATEMENT OF POLICY It is the policy of Intuitive Surgical, Inc. (the “Company”) to prohibit the unauthorized disclosure of any Material Non-Public Information acquired in the workplace and the misuse of Material Non-Public Information in securities trading. 2.ADMINISTRATION The Chief Financ |
|
| January 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-307 |
|
| January 23, 2025 |
Exhibit 99.2 Contact: Peper Long, Intuitive +1-202-446-7748 – mobile Intuitive Announces Plans to Establish Direct Presence in Italy, Spain, Portugal Acquisition of distributor business expands Intuitive’s investment and footprint in Europe SUNNYVALE, Calif., January 21, 2025, – Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surge |
|
| January 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2025 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| January 23, 2025 |
INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS SUNNYVALE, CALIF. January 23, 2025 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2024. Q4 Highlights •Worldwide da Vinci procedures gr |
|
| January 15, 2025 |
Exhibit 99.2 Intuitive Surgical, Inc. Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics Three Months Ended Twelve Months Ended December 31, 2024 December 31, 2023 Change December 31, 2024 December 31, 2023 Change Revenue ($millions) Instruments and accessories (“I&A”) $ 1,411.5 $ 1,143.7 23 % $ 5,079.0 $ 4,276.6 19 % Systems 654.6 480.2 36 % 1,966.0 1,679.7 17 % Services 347.4 30 |
|
| January 15, 2025 |
INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2024 RESULTS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2024 RESULTS SUNNYVALE, CALIF. January 15, 2025 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2024 financial re |
|
| January 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2025 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| January 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 1, 2025 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| October 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuit |
|
| October 17, 2024 |
INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS SUNNYVALE, CALIF. October 17, 2024 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2024. Q3 Highlights •Worldwide da Vinci procedures gr |
|
| October 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2024 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2024 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commission |
|
| July 25, 2024 |
Intuitive President David J. Rosa Appointed to Intuitive Board of Directors Exhibit 99.1 Contact: Global Public Affairs +1-202-997-7373 Intuitive President David J. Rosa Appointed to Intuitive Board of Directors Sunnyvale, Calif., July 25, 2024 – Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that Intuitive President David J. Rosa has been appointed to the Company’s Board of Direc |
|
| July 19, 2024 |
Exhibit 107.1 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) Intuitive Surgical, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stock $0.001 pa |
|
| July 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive S |
|
| July 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTUITIVE SURGICAL, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 77-0416458 (I.R.S. Employer Identification No.) 1020 Kifer Road Sunnyvale, California 94086 (Address of Principal Executive Offices including Zip Cod |
|
| July 18, 2024 |
INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS SUNNYVALE, CALIF. July 18, 2024 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2024. Q2 Highlights •Worldwide da Vinci procedures grew appr |
|
| July 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2024 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| May 22, 2024 |
Conflict Minerals Report for the reporting period January 1, Exhibit 1.01 CONFLICT MINERALS REPORT Pursuant to Rule 13P-1 under the Securities Exchange Act (17 CFR 240.13P-1) FOR THE REPORTING PERIOD FROM JANUARY 1, 2023, TO DECEMBER 31, 2023 I. INTRODUCTION This Conflict Minerals Report (“report”) of Intuitive Surgical, Inc. (“Intuitive,” “we,” or “us”) for the year ended December 31, 2023, is presented to comply with Rule 13p-1 under the Securities Exchan |
|
| May 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 1020 Kifer Road Sunnyvale, California 94086 (Address of principal execu |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2024 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| April 30, 2024 |
Amended and Restated Intuitive Surgical, Inc. 2000 Employee Stock Purchase Plan EXHIBIT 10.2 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2000 EMPLOYEE STOCK PURCHASE PLAN (As Adopted by the Board of Directors on March 17, 2000) (Approved by the Shareholders on April 30, 2000) (Amendment Adopted by the Board of Directors on February 4, 2010) (Amendment and Restatement Adopted by the Board of Directors on February 2, 2017) (Approved by the Shareholders on April 20, 2017) (Ame |
|
| April 30, 2024 |
Intuitive Surgical, Inc. Amended and Restated 2010 Incentive Award Plan, as amended and restated. EXHIBIT 10.1 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN (Amendment and Restatement Adopted by the Board of Directors on March 6, 2024) (Approved by the Shareholders on April 25, 2024) ARTICLE 1. PURPOSE The purpose of the Intuitive Surgical, Inc. 2010 Incentive Award Plan, as amended and restated from time to time (the “Plan”) is to promote the success and enhance the |
|
| April 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive |
|
| April 18, 2024 |
INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS SUNNYVALE, CALIF. April 18, 2024 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2024. Q1 Highlights •Worldwide da Vinci procedures grew app |
|
| April 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2024 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| March 14, 2024 |
Exhibit 99.1 Contact: Global Public Affairs +1-202-997-7373 Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5 Da Vinci 5 builds on decades of Intuitive technology and millions of robotic procedures Sunnyvale, Calif., March 14, 2024 – Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced t |
|
| March 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2024 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commission |
|
| March 8, 2024 |
Annual Report 2023 Intuitive Surgical, Inc. intuitive.comIntuitive Annual Report 2023 Dear Owner, At Intuitive, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints. We envision a future of care that is less invasive and profoundly better, where diseases are identified early a |
|
| March 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of |
|
| March 8, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confid |
|
| February 14, 2024 |
ISRG / Intuitive Surgical, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10) INTUITIVE SURGICAL INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 46120E602 (CUSIP NUMBER) December 31, 2023 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Sched |
|
| February 13, 2024 |
ISRG / Intuitive Surgical, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01218-intuitivesurgicalinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Intuitive Surgical Inc Title of Class of Securities: Common Stock CUSIP Number: 46120E602 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to |
|
| January 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-307 |
|
| January 31, 2024 |
Intuitive Surgical, Inc. Subsidiaries. Exhibit 21.1 INTUITIVE SURGICAL, INC. SUBSIDIARIES (All 100% owned other than Intuitive Surgical-Fosun (HongKong) Co., Ltd. and Intuitive Surgical-Fosun Medical Technology (Shanghai) Co., Ltd.) Subsidiaries of the Registrant State or Other Jurisdiction of Incorporation Intuitive Fluorescence Imaging LLC Delaware, U.S. Intuitive Surgical AB Sweden Intuitive Surgical ApS Denmark Intuitive Surgical A |
|
| January 31, 2024 |
Policy for Recovery of Erroneously Awarded Compensation INTUITIVE SURGICAL, INC. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Intuitive Surgical, Inc. (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of October 2, 2023 (the “Effective Date”). Capitalized terms used in the text of this Policy but not otherwise defined herein are defined in Section 11. 1.Persons Subject to Po |
|
| January 25, 2024 |
ISRG / Intuitive Surgical, Inc. / BlackRock Inc. Passive Investment SC 13G/A 1 us46120e6023012524.txt us46120e6023012524.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 10) INTUITIVE SURGICAL INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 46120E602 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriat |
|
| January 23, 2024 |
INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS SUNNYVALE, CALIF. January 23, 2024 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2023. Q4 Highlights •Worldwide da Vinci procedures gr |
|
| January 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2024 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| January 9, 2024 |
Exhibit 99.2 Intuitive Surgical, Inc. Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics Three Months Ended Twelve Months Ended December 31, 2023 December 31, 2022 Change December 31, 2023 December 31, 2022 Change Revenue ($millions) Instruments and accessories (“I&A”) $ 1,143.7 $ 940.7 22 % $ 4,276.6 $ 3,517.9 22 % Systems 480.2 451.0 6 % 1,679.7 1,680.1 — % Services 304.4 263.3 |
|
| January 9, 2024 |
INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2023 RESULTS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2023 RESULTS SUNNYVALE, CALIF. January 9, 2024 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2023 financial res |
|
| January 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2024 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissio |
|
| October 31, 2023 |
Intuitive Appoints Sreelakshmi Kolli to its Board of Directors Exhibit 99.1 Contact: Global Public Affairs +1-202-997-7373 Intuitive Appoints Sreelakshmi Kolli to its Board of Directors SUNNYVALE, CALIF. October 31, 2023 – Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the appointment of Sreelakshmi Kolli, executive vice president and chief digital officer at Align T |
|
| October 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2023 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| October 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuit |
|
| October 19, 2023 |
INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS SUNNYVALE, CALIF. October 19, 2023 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2023. Q3 Highlights •Worldwide da Vinci procedures gr |
|
| October 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2023 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| July 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive S |
|
| July 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2023 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| July 20, 2023 |
INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS SUNNYVALE, CALIF. July 20, 2023 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2023. Q2 Highlights •Worldwide da Vinci procedures grew appr |
|
| May 24, 2023 |
EX-1.01 2 a2023conflictmineralsex-101.htm EX-1.01 Exhibit 1.01 CONFLICT MINERALS REPORT Pursuant to Rule 13P-1 under the Securities Exchange Act (17 CFR 240.13P-1) FOR THE REPORTING PERIOD FROM JANUARY 1, 2022, TO DECEMBER 31, 2022 I. INTRODUCTION This Conflict Minerals Report (“report”) of Intuitive Surgical, Inc. (“Intuitive,” “we,” or “us”) for the year ended December 31, 2022, is presented to |
|
| May 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 1020 Kifer Road Sunnyvale, California 94086 (Address of principal execu |
|
| May 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2023 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| May 16, 2023 |
Exhibit 99.1 Contact: Global Public Affairs +1-202-997-7373 INTUITIVE ANNOUNCES EXECUTIVE LEADERSHIP CHANGES Dave Rosa named President; Gary Guthart remains Chief Executive Officer SUNNYVALE, CALIF. May 16, 2023 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced executive leadership changes |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2023 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| April 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive |
|
| April 18, 2023 |
INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS SUNNYVALE, CALIF. April 18, 2023 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2023. Q1 Highlights •Worldwide da Vinci procedures grew app |
|
| April 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2023 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| March 27, 2023 |
Notice of Exempt Solicitation Notice of Exempt Solicitation Under Rule 14a-103 (Voluntary Submission) Name of Corporate Registrant: Intuitive Surgical, Inc. |
|
| March 10, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confid |
|
| March 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of |
|
| February 14, 2023 |
ISRG / Intuitive Surgical, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9) INTUITIVE SURGICAL INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 46120E602 (CUSIP NUMBER) December 31, 2022 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedu |
|
| February 10, 2023 |
Exhibit 10.11 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN PERFORMANCE STOCK UNIT AWARD GRANT NOTICE Intuitive Surgical, Inc., a Delaware corporation, (the “Company”), pursuant to its Amended and Restated 2010 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (the “Participant”), an award of performance stock units |
|
| February 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-307 |
|
| February 10, 2023 |
AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN GLOBAL STOCK OPTION GRANT NOTICE Intuitive Surgical, Inc., a Delaware corporation (the “Company”), pursuant to its Amended and Restated 2010 Incentive Award Plan (the “Plan”), hereby grants to the holder listed below (“Participant”) an option to purchase the number of shares of the Company’s Common Stock (the “Option”) set for |
|
| February 10, 2023 |
AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN GLOBAL RESTRICTED STOCK UNIT GRANT NOTICE Intuitive Surgical, Inc., a Delaware corporation (the “Company”), pursuant to its Amended and Restated 2010 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant”) the number of Restricted Stock Units (the “RSUs”) set fo |
|
| February 10, 2023 |
Intuitive Surgical, Inc. Subsidiaries. Exhibit 21.1 INTUITIVE SURGICAL, INC. SUBSIDIARIES (All 100% owned other than Intuitive Surgical-Fosun (HongKong) Co., Ltd. and Intuitive Surgical-Fosun Medical Technology (Shanghai) Co., Ltd.) Subsidiaries of the Registrant State or Other Jurisdiction of Incorporation Intuitive Fluorescence Imaging LLC Delaware, U.S. Intuitive Surgical AB Sweden Intuitive Surgical ApS Denmark Intuitive Surgical A |
|
| February 9, 2023 |
ISRG / Intuitive Surgical, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01176-intuitivesurgicalinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Intuitive Surgical Inc. Title of Class of Securities: Common Stock CUSIP Number: 46120E602 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to |
|
| February 3, 2023 |
ISRG / Intuitive Surgical, Inc. / BlackRock Inc. Passive Investment SC 13G/A 1 us46120e6023020323.txt us46120e6023020323.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 9) INTUITIVE SURGICAL INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 46120E602 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate |
|
| January 24, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 24, 2023 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| January 24, 2023 |
INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS SUNNYVALE, CALIF. January 24, 2023 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2022. Q4 Highlights •Worldwide da Vinci procedures gr |
|
| January 11, 2023 |
Exhibit 99.2 Intuitive Surgical, Inc. Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics Three Months Ended Twelve Months Ended December 31, 2022 December 31, 2021 Change December 31, 2022 December 31, 2021 Change Revenue ($Millions) Instruments and Accessories $ 940.7 $ 842.8 12 % $ 3,517.9 $ 3,100.5 13 % Systems 451.0 469.9 (4) % 1,680.1 1,693.4 (1) % Services 263.3 238.0 11 % 1 |
|
| January 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2023 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| January 11, 2023 |
INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2022 RESULTS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2022 RESULTS SUNNYVALE, CALIF. January 11, 2023 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2022 financial re |
|
| October 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2022 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| October 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuit |
|
| October 18, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2022 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| October 18, 2022 |
INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS SUNNYVALE, CALIF. October 18, 2022 ? Intuitive (the ?Company?) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2022. Q3 Highlights ?Worldwide da Vinci procedures gr |
|
| August 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2022 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| July 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTUITIVE SURGICAL, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 77-0416458 (I.R.S. Employer Identification No.) 1020 Kifer Road Sunnyvale, California 94086 (Address of Principal Executive Offices including Zip Cod |
|
| July 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive S |
|
| July 22, 2022 |
Exhibit 107.1 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) Intuitive Surgical, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stock $0.001 pa |
|
| July 21, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2022 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| July 21, 2022 |
INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS SUNNYVALE, CALIF. July 21, 2022 ? Intuitive (the ?Company?) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2022. All prior year per-share information has been retroact |
|
| May 26, 2022 |
Exhibit 1.01 CONFLICT MINERALS REPORT Pursuant to Rule 13P-1 under the Securities Exchange Act (17 CFR 240.13P-1) FOR THE REPORTING PERIOD FROM JANUARY 1, 2021, TO DECEMBER 31, 2021 I. INTRODUCTION This Conflict Minerals Report (?report?) of Intuitive Surgical, Inc. (?Intuitive,? ?we,? or ?us?) for the year ended December 31, 2021, is presented to comply with Rule 13p-1 under the Securities Exchan |
|
| May 26, 2022 |
SD 1 isrg-2022sdconflictminerals.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 1020 Kifer Road Sunnyvale, Cali |
|
| May 3, 2022 |
2010 Incentive Award Plan, as amended and restated. EXHIBIT 10.1 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN (Amendment and Restatement Adopted by the Board of Directors on March 7, 2022) (Approved by the Shareholders on April 28, 2022) ARTICLE 1. PURPOSE The purpose of the Intuitive Surgical, Inc. 2010 Incentive Award Plan, as amended and restated from time to time (the ?Plan?) is to promote the success and enhance the |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2022 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| April 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive |
|
| April 21, 2022 |
INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS SUNNYVALE, CALIF. April 21, 2022 ? Intuitive (the ?Company?) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2022. All prior year per-share information has been retroac |
|
| April 21, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2022 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| March 14, 2022 |
United States securities and exchange commission logo March 14, 2022 Jamie Samath Chief Financial Officer INTUITIVE SURGICAL INC 1020 Kifer Road Sunnyvale, CA 94086 Re: INTUITIVE SURGICAL INC 10-K for the Fiscal Year Ended December 31, 2021 Filed February 3, 2022 File No. |
|
| March 9, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confid |
|
| March 8, 2022 |
March 8, 2022 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Washington, D.C. 20549 Attn: Julie Sherman and Daniel Gordon VIA EDGAR Re: Intuitive Surgical, Inc. Form 10-K for the Fiscal Year Ended December 31, 2021 Filed February 3, 2022 File No. 000-30713 Dear Ms. Sherman and Mr. Gordon: This letter responds to the comment letter (the ?Letter?) fro |
|
| March 1, 2022 |
United States securities and exchange commission logo March 1, 2022 Jamie Samath Chief Financial Officer INTUITIVE SURGICAL INC 1020 Kifer Road Sunnyvale, CA 94086 Re: INTUITIVE SURGICAL INC 10-K for the Fiscal Year Ended December 31, 2021 Filed February 3, 2022 File No. |
|
| February 14, 2022 |
ISRG / Intuitive Surgical, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8) INTUITIVE SURGICAL INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 46120E602 (CUSIP NUMBER) December 31, 2021 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedu |
|
| February 10, 2022 |
ISRG / Intuitive Surgical, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01186-intuitivesurgicalinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Intuitive Surgical Inc. Title of Class of Securities: Common Stock CUSIP Number: 46120E602 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to |
|
| February 7, 2022 |
ISRG / Intuitive Surgical, Inc. / BlackRock Inc. Passive Investment us46120e6023020722.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 8) INTUITIVE SURGICAL INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 46120E602 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan |
|
| February 3, 2022 |
s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934. Exhibit 4.2 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2021, Intuitive Surgical, Inc. (?Intuitive Surgical,? the ?Company,? ?we,? ?us? or ?our?) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?): our common stock, $0.001 par value |
|
| February 3, 2022 |
Intuitive Surgical, Inc. Subsidiaries. Exhibit 21.1 INTUITIVE SURGICAL, INC. SUBSIDIARIES (All 100% owned other than Intuitive Surgical-Fosun (HongKong) Co., Ltd. and Intuitive Surgical-Fosun Medical Technology (Shanghai) Co., Ltd.) Subsidiaries of the Registrant State or Other Jurisdiction of Incorporation Intuitive Fluorescence Imaging LLC Delaware, U.S. Intuitive Surgical AB Sweden Intuitive Surgical ApS Denmark Intuitive Surgical A |
|
| February 3, 2022 |
Form of Amended and Restated Intuitive Surgical, Inc. 2010 Incentive Award Plan Global Exhibit 10.11 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN PERFORMANCE STOCK UNIT AWARD GRANT NOTICE Intuitive Surgical, Inc., a Delaware corporation, (the ?Company?), pursuant to its Amended and Restated 2010 Incentive Award Plan, as amended from time to time (the ?Plan?), hereby grants to the holder listed below (the ?Participant?), an award of performance stock units |
|
| February 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (MARK ONE) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-307 |
|
| January 20, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 20, 2022 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| January 20, 2022 |
INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS SUNNYVALE, CALIF. January 20, 2022 ? Intuitive (the ?Company?) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2021. Reported revenue and procedure results are cons |
|
| January 12, 2022 |
INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2021 RESULTS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2021 RESULTS SUNNYVALE, CALIF. January 12, 2022 ? Intuitive (the ?Company?) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2021 financial re |
|
| January 12, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2022 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| January 12, 2022 |
Exhibit 99.2 Intuitive Surgical, Inc. Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics Three Months Ended Twelve Months Ended December 31, 2021 December 31, 2020 Change December 31, 2021 December 31, 2020 Change Revenue ($Millions) Instruments and Accessories $ 842.8 $ 746.9 13 % $ 3,100.5 $ 2,455.7 26 % Systems 469.9 366.8 28 % 1,693.4 1,178.9 44 % Services 238.0 215.4 10 % 916 |
|
| October 20, 2021 |
Amendment to Amended and Restated Certificate of Incorporation of the Company. EXHIBIT 3.1 CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INTUITIVE SURGICAL, INC. Intuitive Surgical, Inc. (the ?Corporation?), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify that: FIRST: Paragraph (A) of Article IV of the Amended and Restated Certificate of Incorporation is he |
|
| October 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| October 19, 2021 |
Exhibit 99.2 Intuitive Announces Executive Leadership Changes Moves reflect growth and help advance minimally invasive care ?Marshall Mohr named new EVP for Global Business Services ?Jamie Samath named CFO ?Dave Rosa named new Chief Strategy and Growth Officer ?Henry Charlton named Chief Commercial Officer SUNNYVALE, Calif., Oct. 19, 2021 - Intuitive (Nasdaq: ISRG), a global technology leader in m |
|
| October 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2021 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| October 19, 2021 |
INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS SUNNYVALE, CALIF. October 19, 2021 ? Intuitive (the ?Company?) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2021. All share and per-share information have been r |
|
| September 23, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 20, 2021 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commis |
|
| August 19, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confid |
|
| August 5, 2021 |
PRE 14A 1 isrg-20210805xpre14a.htm PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate |
|
| August 5, 2021 |
INTUITIVE BOARD OF DIRECTORS APPROVES A THREE-FOR-ONE STOCK SPLIT Exhibit 99.1 INTUITIVE BOARD OF DIRECTORS APPROVES A THREE-FOR-ONE STOCK SPLIT SUNNYVALE, Calif., August 5, 2021 ? Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that its Board of Directors has approved a three-for-one split of the Company?s common stock to be effected through an Amendment to the Company? |
|
| August 5, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2021 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| August 5, 2021 |
Employee Frequently Asked Questions & Answers About the Stock Split Exhibit 99.2 Employee Frequently Asked Questions & Answers About the Stock Split All of the following information is qualified in its entirety by the information in our preliminary proxy statement, which has been filed with the SEC. Question 1. What is a stock split, and what is the record date for the Intuitive stock split? In a 3-for-1 stock split, each stockholder receives 2 additional shares f |
|
| July 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTUITIVE SURGICAL, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 77-0416458 (I.R.S. Employer Identification No.) 1020 Kifer Road Sunnyvale, California 94086 (Address of Principal Executive Offices including Zip Cod |
|
| July 21, 2021 |
EXHIBIT 3.1 CORRECTED AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INTUITIVE SURGICAL, INC. INTUITIVE SURGICAL, INC., a corporation organized and existing under the laws of the state of Delaware (the ?Corporation?) hereby certifies that: 1. The name of the Corporation is Intuitive Surgical, Inc. The name under which this corporation was originally incorporated is Intuitive Surgical Devices |
|
| July 21, 2021 |
EXHIBIT 10.1 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN (Amendment and Restatement Adopted by the Board of Directors on March 6, 2021) (Approved by the Shareholders on April 22, 2021) ARTICLE 1. PURPOSE The purpose of the Intuitive Surgical, Inc. 2010 Incentive Award Plan, as amended and restated from time to time (the ?Plan?) is to promote the success and enhance the |
|
| July 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000 |
|
| July 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2021 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| July 20, 2021 |
INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS SUNNYVALE, CALIF. July 20, 2021 ? Intuitive (the ?Company?) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2021. Q2 Highlights ?Worldwide da Vinci procedures grew appr |
|
| May 28, 2021 |
Exhibit 1.01 CONFLICT MINERALS REPORT Pursuant to Rule 13P-1 under the Securities Exchange Act (17 CFR 240.13P-1) FOR THE REPORTING PERIOD FROM JANUARY 1, 2020, TO DECEMBER 31, 2020 I. INTRODUCTION This Conflict Minerals Report (?report?) of Intuitive Surgical, Inc. (?Intuitive,? ?we,? or ?us?) for the year ended December 31, 2020, is presented to comply with Rule 13p-1 under the Securities Exchan |
|
| May 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 1020 Kifer Road Sunnyvale, California 94086 (Address of principal execu |
|
| April 26, 2021 |
2010 Incentive Award Plan, as amended and restated. EXHIBIT 10.1 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN (Amendment and Restatement Adopted by the Board of Directors on March 6, 2021) (Approved by the Shareholders on April 22, 2021) ARTICLE 1. PURPOSE The purpose of the Intuitive Surgical, Inc. 2010 Incentive Award Plan, as amended and restated from time to time (the ?Plan?) is to promote the success and enhance the |
|
| April 26, 2021 |
Intuitive Appoints Dr. Monica P. Reed to its Board of Directors Exhibit 99.1 Intuitive Appoints Dr. Monica P. Reed to its Board of Directors SUNNYVALE, Calif., April 26, 2021 ? Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the election of Dr. Monica P. Reed, a former AdventHealth executive, to its board of directors, effective April 22, 2021. ?Dr. Reed brings decades |
|
| April 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2021 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| April 21, 2021 |
EXHIBIT 3.1 CORRECTED AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INTUITIVE SURGICAL, INC. INTUITIVE SURGICAL, INC., a corporation organized and existing under the laws of the state of Delaware (the ?Corporation?) hereby certifies that: 1. The name of the Corporation is Intuitive Surgical, Inc. The name under which this corporation was originally incorporated is Intuitive Surgical Devices |
|
| April 21, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00 |
|
| April 20, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 20, 2021 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| April 20, 2021 |
INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS SUNNYVALE, CALIF. April 20, 2021 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2021. Q1 Highlights •Worldwide da Vinci procedures grew app |
|
| March 10, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confid |
|
| March 10, 2021 |
DEFA14A 1 isrg-20201231xdefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminar |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7) INTUITIVE SURGICAL INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 46120E602 (CUSIP NUMBER) December 31, 2020 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedu |
|
| February 10, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-307 |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: Intuitive Surgical Inc. Title of Class of Securities: Common Stock CUSIP Number: 46120E602 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is file |
|
| February 10, 2021 |
Intuitive Surgical, Inc. Subsidiaries. Exhibit 21.1 INTUITIVE SURGICAL, INC. SUBSIDIARIES (All 100% owned other than Intuitive Surgical-Fosun (HongKong) Co., Ltd. and Intuitive Surgical-Fosun Medical Technology (Shanghai) Co., Ltd.) Subsidiaries of the Registrant State or Other Jurisdiction of Incorporation Intuitive Surgical AB Sweden Intuitive Surgical ApS Denmark Intuitive Surgical Australia Proprietary Limited Australia Intuitive S |
|
| February 10, 2021 |
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2020, Intuitive Surgical, Inc. (“Intuitive Surgical,” the “Company,” “we,” “us” or “our”) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, $0.001 par value |
|
| February 8, 2021 |
SCHEDULE 13G Amendment No. 4 INTUITIVE SURGICAL INC COMMON STOCK Cusip #46120E602 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #46120E602 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 742,945 Item 6: 0 Item 7: 5,190,152 Item 8: 0 Item 9: 5,190,152 Item 11: |
|
| February 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2021 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| February 1, 2021 |
Amended and Restated Bylaws of the Company. EXHIBIT 3.1 AMENDED AND RESTATED BYLAWS OF INTUITIVE SURGICAL, INC. (A DELAWARE CORPORATION) TABLE OF CONTENTS Article I OFFICES 1 Section 1. Registered Office 1 Section 2. Other Offices 1 Article II CORPORATE SEAL 1 Section 3. Corporate Seal 1 Article III STOCKHOLDERS’ MEETINGS 1 Section 4. Place Of Meetings 1 Section 5. Annual Meetings 1 Section 6. Special Meetings 13 Section 7. Notice Of Meetin |
|
| January 29, 2021 |
us46120e6023012921.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 7) INTUITIVE SURGICAL INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 46120E602 - (CUSIP Number) December 31, 2020 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan |
|
| January 21, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2021 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| January 21, 2021 |
INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS EX-99.1 2 a20201231ex-991.htm EX-99.1 Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS SUNNYVALE, CALIF. January 21, 2021 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2020. Reported |
|
| January 13, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2021 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| January 13, 2021 |
INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2020 RESULTS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2020 RESULTS SUNNYVALE, CALIF. January 13, 2021 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2020 financial re |
|
| January 13, 2021 |
Intuitive Surgical, Inc. Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics Exhibit 99.2 Intuitive Surgical, Inc. Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics Three Months Ended Twelve Months Ended December 31, 2020 December 31, 2019 Change December 31, 2020 December 31, 2019 Change Revenue ($Millions) Instruments and Accessories $ 746.9 $ 671.2 11 % $ 2,455.7 $ 2,408.2 2 % Systems 366.8 416.2 (12) % 1,178.9 1,346.1 (12) % Services 215.4 190.3 13 % |
|
| October 19, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| October 19, 2020 |
Amended and Restated Certificate of Incorporation of the Company, as Amended. EXHIBIT 3.1 CORRECTED AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INTUITIVE SURGICAL, INC. INTUITIVE SURGICAL, INC., a corporation organized and existing under the laws of the state of Delaware (the “Corporation”) hereby certifies that: 1. The name of the Corporation is Intuitive Surgical, Inc. The name under which this corporation was originally incorporated is Intuitive Surgical Devices |
|
| October 15, 2020 |
INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS SUNNYVALE, CALIF. October 15, 2020 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2020. Q3 Highlights •Worldwide da Vinci procedures in |
|
| October 15, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2020 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| July 23, 2020 |
EXHIBIT 10.3 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN GLOBAL RESTRICTED STOCK UNIT GRANT NOTICE Intuitive Surgical, Inc., a Delaware corporation (the “Company”), pursuant to its Amended and Restated 2010 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant”) the number of Restricted Stock Units (the “ |
|
| July 23, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INTUITIVE SURGICAL, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 77-0416458 (I.R.S. Employer Identification No.) 1020 Kifer Road Sunnyvale, California 94086 (Address of Principal Executive Offices including Zip Cod |
|
| July 23, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000 |
|
| July 23, 2020 |
EXHIBIT 10.2 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN GLOBAL STOCK OPTION GRANT NOTICE Intuitive Surgical, Inc., a Delaware corporation (the “Company”), pursuant to its Amended and Restated 2010 Incentive Award Plan (the “Plan”), hereby grants to the holder listed below (“Participant”) an option to purchase the number of shares of the Company’s Common Stock (the “Opt |
|
| July 23, 2020 |
Amended and Restated Certificate of Incorporation of the Company, as Amended EXHIBIT 3.1 CORRECTED AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INTUITIVE SURGICAL, INC. INTUITIVE SURGICAL, INC., a corporation organized and existing under the laws of the state of Delaware (the “Corporation”) hereby certifies that: 1. The name of the Corporation is Intuitive Surgical, Inc. The name under which this corporation was originally incorporated is Intuitive Surgical Devices |
|
| July 21, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2020 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| July 21, 2020 |
INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS SUNNYVALE, CALIF. July 21, 2020 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2020. Q2 Highlights •Worldwide da Vinci procedures decreased |
|
| June 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 1020 Kifer Road Sunnyvale, California 94086 (Address of principal execu |
|
| June 1, 2020 |
Exhibit 1.01 CONFLICT MINERALS REPORT Pursuant to Rule 13P-1 under the Securities Exchange Act (17 CFR 240.13P-1) FOR THE REPORTING PERIOD FROM JANUARY 1, 2019, TO DECEMBER 31, 2019 I. INTRODUCTION This Conflict Minerals Report (“report”) of Intuitive Surgical, Inc. (“Intuitive,” “we,” or “us”) for the year ended December 31, 2019, is presented to comply with Rule 13p-1 under the Securities Exchan |
|
| April 28, 2020 |
Intuitive Appoints Joseph C. Beery to its Board of Directors Exhibit 99.1 Intuitive Appoints Joseph C. Beery to its Board of Directors SUNNYVALE, Calif., April 27, 2020 – Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the election of Joseph C. Beery to its board of directors, effective April 23, 2020. “Joe has broad experience leading digital business capabilities, |
|
| April 28, 2020 |
EXHIBIT 3.1 CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INTUITIVE SURGICAL, INC. Pursuant to § 242 of the General Corporation Law of the State of Delaware Intuitive Surgical, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify: FIRST: That Paragraph (E) of |
|
| April 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2020 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| April 28, 2020 |
Amended and Restated Bylaws of Intuitive Surgical, Inc. EXHIBIT 3.2 AMENDED AND RESTATED BYLAWS OF INTUITIVE SURGICAL, INC. (A DELAWARE CORPORATION) TABLE OF CONTENTS ARTICLE I OFFICES 1 Section 1. Registered Office 1 Section 2. Other Offices 1 ARTICLE II CORPORATE SEAL 1 Section 3. Corporate Seal 1 ARTICLE III STOCKHOLDERS’ MEETINGS 1 Section 4. Place Of Meetings 1 Section 5. Annual Meetings 1 Section 6. Special Meetings 13 Section 7. Notice Of Meetin |
|
| April 28, 2020 |
2010 Incentive Award Plan, as amended and restated. EXHIBIT 10.1 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN (As Adopted by the Board of Directors on February 4, 2010) (Amendment and Restatement Adopted by the Board of Directors on February 3, 2011) (Approved by the Shareholders on April 21, 2011) (Amendment and Restatement Adopted by the Board of Directors on February 2, 2012) (Approved by the Shareholders on April 19, |
|
| April 28, 2020 |
Intuitive Provides Update on Supporting Customers, Communities & Employees during COVID-19 Exhibit 99.2 Intuitive Provides Update on Supporting Customers, Communities & Employees during COVID-19 SUNNYVALE, Calif., April 28, 2020 – Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today provided an update on its efforts to support customers, communities, and its employees during the COVID-19 pandemic. “The COVID-1 |
|
| April 17, 2020 |
Form of Intuitive Surgical, Inc. 2010 Incentive Award Plan Restricted Stock Unit Grant Notice. EX-10.2 3 ex-102x2010planrsunoti.htm EX-10.2 EXHIBIT 10.2 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN GLOBAL RESTRICTED STOCK UNIT GRANT NOTICE Intuitive Surgical, Inc., a Delaware corporation (the “Company”), pursuant to its Amended and Restated 2010 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant” |
|
| April 17, 2020 |
Form of Intuitive Surgical, Inc. 2010 Incentive Award Plan Stock Option Grant Notice. EXHIBIT 10.1 AMENDED AND RESTATED INTUITIVE SURGICAL, INC. 2010 INCENTIVE AWARD PLAN GLOBAL STOCK OPTION GRANT NOTICE Intuitive Surgical, Inc., a Delaware corporation (the “Company”), pursuant to its Amended and Restated 2010 Incentive Award Plan (the “Plan”), hereby grants to the holder listed below (“Participant”) an option to purchase the number of shares of the Company’s Common Stock (the “Opt |
|
| April 17, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00 |
|
| April 16, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2020 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| April 16, 2020 |
INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS SUNNYVALE, CALIF. April 16, 2020 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2020. Procedure volume and systems placements in the quarte |
|
| April 8, 2020 |
Intuitive Announces Preliminary First Quarter Results; Provides Update on COVID-19 Impact EX-99.1 2 a20200331ex-991prelimi.htm EX-99.1 Exhibit 99.1 Intuitive Announces Preliminary First Quarter Results; Provides Update on COVID-19 Impact SUNNYVALE, Calif., April 08, 2020 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary first quarter 2020 operationa |
|
| April 8, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 2020 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| March 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2020 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
|
| March 13, 2020 |
ISRG / Intuitive Surgical, Inc. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of |
|
| March 13, 2020 |
ISRG / Intuitive Surgical, Inc. DEF 14A - - DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confid |
|
| February 27, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: x Preliminary Proxy Statement ? Confid |
|
| February 14, 2020 |
ISRG / Intuitive Surgical, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6) INTUITIVE SURGICAL INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 46120E602 (CUSIP NUMBER) December 31, 2019 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedu |
|
| February 12, 2020 |
ISRG / Intuitive Surgical, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: Intuitive Surgical Inc Title of Class of Securities: Common Stock CUSIP Number: 46120E602 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| February 7, 2020 |
Intuitive Surgical, Inc. Subsidiaries. Exhibit 21.1 INTUITIVE SURGICAL, INC. SUBSIDIARIES (All 100% owned other than Intuitive Surgical-Fosun (HongKong) Co., Ltd. and Intuitive Surgical-Fosun Medical Technology (Shanghai) Co., Ltd.) Subsidiaries of the Registrant State or Other Jurisdiction of Incorporation Intuitive Surgical AB Sweden Intuitive Surgical ApS Denmark Intuitive Surgical Australia Proprietary Limited Australia Intuitive S |
|
| February 7, 2020 |
ISRG / Intuitive Surgical, Inc. / FMR LLC / Fidelity Passive Investment SCHEDULE 13G Amendment No. 3 INTUITIVE SURGICAL INC COMMON STOCK Cusip #46120E602 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #46120E602 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 928,839 Item 6: 0 Item 7: 7,034,104 Item 8: 0 Item 9: 7,034,104 Item 11: |
|
| February 7, 2020 |
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2019, Intuitive Surgical, Inc. (“Intuitive Surgical,” the “Company,” “we,” “us” or “our”) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, $0.001 par value |
|
| February 7, 2020 |
Consulting Agreement between Intuitive Surgical, Inc. and Sal Brogna. Exhibit 10.14 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT ("Consulting Agreement") is made and entered into this 14th day of October, 2019 by and between Intuitive Surgical, Inc. ("Company") and Sal Brogna ("Brogna"). In consideration of the mutual promises made herein, Brogna and Company agree as follows: 1. Engagement and Term. Contingent upon the parties' execution of a Separation Agreement |
|
| February 7, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-307 |
|
| February 5, 2020 |
ISRG / Intuitive Surgical, Inc. / BlackRock Inc. Passive Investment us46120e6023020420.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 6) INTUITIVE SURGICAL INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 46120E602 - (CUSIP Number) December 31, 2019 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan |
|
| February 3, 2020 |
Exhibit 99.1 Intuitive Announces Retirement of Board Chair Lonnie M. Smith; Dr. Craig H. Barratt Succeeds Smith as New Chair SUNNYVALE, Calif., Monday, Feb. 3, 2020– Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that Lonnie M. Smith has decided to retire from the company’s board of directors when his ter |
|
| February 3, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2020 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| January 23, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2020 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| January 23, 2020 |
INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS SUNNYVALE, CALIF. January 23, 2020 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2019. Reported revenue and procedure results are cons |
|
| January 9, 2020 |
Exhibit 99.2 Intuitive Surgical, Inc. Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics Three Months Ended Twelve Months Ended December 31, 2019 December 31, 2018 Change December 31, 2019 December 31, 2018 Change Revenue ($Millions) Instruments and Accessories $ 671.2 $ 539.3 24 % $ 2,408.2 $ 1,962.0 23 % Systems 416.2 340.6 22 % 1,346.1 1,127.1 19 % Services 190.3 166.6 14 % 724 |
|
| January 9, 2020 |
INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2019 RESULTS Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2019 RESULTS SUNNYVALE, CALIF. January 9, 2020 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2019 financial res |
|
| January 9, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2020 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissio |
|
| October 18, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| October 17, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2019 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commissi |
|
| October 17, 2019 |
INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS EX-99.1 2 a20190930ex-991.htm EX-99.1 Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS SUNNYVALE, CALIF. October 17, 2019 - Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2019. Q3 Highli |
|
| July 30, 2019 |
POWER OF ATTORNEY Know all by these present that the undersigned hereby authorizes (i) Lori Serrano, (ii) Donna Spinola, (iii) Brian King and (iv) Siang Chin of Intuitive Surgical, Inc. |
|
| July 29, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2019 INTUITIVE SURGICAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-30713 77-0416458 (State or other jurisdiction of incorporation) (Commission |
